-
1
المؤلفون: Edford Sinkala, Julius J. Massaga, Oliver Ezechi, Henry Luwaga, Catherine Muwonge, Alexander S. Pym, Duncan Chanda, Moses Joloba, Roxana Rustomjee, Judith Mzyece, Grace Nyakoojo, Vincent Kapotwe, Getnet Yimer, Nathan Kapata, Thuli Mthiyane, Mahnaz Vahedi, Peter Mwaba, Wanze Kohi, Alimuddin Zumla, Beatrice Mutayoba, Francis E. Adatu, Saidi Egwaga, Philip Onyebujoh, Basra Doulla, Bruce Kirenga, Lucinda Lyantumba, Cathy Connolly, Sayoki Mfinanga
المصدر: The Lancet Infectious Diseases. 14:563-571
مصطلحات موضوعية: Adult, Male, Pediatrics, medicine.medical_specialty, Tuberculosis, Anti-HIV Agents, Population, Placebo-controlled study, HIV Infections, Drug Administration Schedule, law.invention, Randomized controlled trial, law, Antiretroviral Therapy, Highly Active, HIV Seropositivity, Clinical endpoint, Humans, Medicine, Prospective Studies, education, Tuberculosis, Pulmonary, Ethambutol, education.field_of_study, business.industry, Pyrazinamide, medicine.disease, CD4 Lymphocyte Count, Infectious Diseases, Female, business, Rifampicin, medicine.drug